Kisunla 350 mg concentrate for solution for infusion
*Company:
Eli Lilly and Company (Ireland) LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Kisunla HCP Risk Minimisation Material
Risk Minimisation Materials
Eli Lilly and Company (Ireland) Limited
 Limited.webp)
Address:
Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA, United KingdomMedical Information E-mail:
ukmedinfo@lilly.comTelephone:
+353 1 661 4377Website:
https://www.lilly.ie